Clinical trial
Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Children
NCT01464138 is registered in ClinicalTrials.gov with Jomaa Pharma GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Children
- Lead sponsor
- Jomaa Pharma GmbH
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2010
- Completion date
- September 30, 2011
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.